Janssen Announces Global License and Development Rights Agreement with Hanmi … – PR Newswire (press release)


Junior College
Janssen Announces Global License and Development Rights Agreement with Hanmi
PR Newswire (press release)
RARITAN, N.J., Nov. 9, 2015 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) announced today that it has obtained worldwide rights, excluding China and Korea, to develop and commercialize oxyntomodulin-based therapies including HM12525A,¬†…
Hanmi Pharmaceutical Signs an Exclusive License Agreement with Janssen Business Wire (press release)
Hanmi Pharmaceutical Signs an Exclusive License Agreement with JanssenJunior College
Hanmi Pharmaceutical bags $915 mln license deal with JanssenThe Korea Herald
The Korea Observer
all 23 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd